Rifaximin for Preventing Progression and Complications in Patients With Decompensated Liver Cirrhosis

Clinical trial NCT05863364 · UNKNOWN

Trial details

NCT number: NCT05863364
Sponsor: Xin Zeng
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Decompensated Cirrhosis

Start date: 2023-08-18
Primary completion: 2025-12-31
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.